Surenaud, Mathieu <br/><br/>
Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination.  [electronic resource] 

 -  PLoS pathogens  09 2019 
 - e1008011 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1553-7374 
<br/><br/><label>Standard No.: </label>10.1371/journal.ppat.1008011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Adult<br/>Anti-Retroviral Agents<br/>Antiviral Agents--pharmacology<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Dendritic Cells--immunology<br/>Drug Therapy, Combination--methods<br/>Epitopes--immunology<br/>Epitopes, T-Lymphocyte--immunology<br/>Female<br/>HIV Infections--immunology<br/>HIV-1--immunology<br/>Humans<br/>Interferon-alpha--metabolism<br/>Male<br/>Middle Aged<br/>Vaccination